The stock of Knight Therapeutics Inc (TSE:GUD) is a huge mover today! About 46,646 shares traded hands. Knight Therapeutics Inc (TSE:GUD) has risen 33.04% since February 5, 2016 and is uptrending. It has outperformed by 16.55% the S&P500.
The move comes after 7 months positive chart setup for the $1.19 billion company. It was reported on Sep, 13 by Barchart.com. We have $13.77 PT which if reached, will make TSE:GUD worth $642.60 million more.
Out of 2 analysts covering Knight Therapeutics (TSE:GUD), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $10 is the highest target while $9.50 is the lowest. The $9.75 average target is 9.06% above today’s ($8.94) stock price. Knight Therapeutics has been the topic of 2 analyst reports since May 12, 2016 according to StockzIntelligence Inc.
Knight Therapeutics Inc is a Canada pharmaceutical company. The company has a market cap of $1.19 billion. The Firm is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It has a 54.93 P/E ratio. It finances other life sciences companies in Canada and internationally.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.